Fig. 4
From: Isoform specific gene expression analysis of KRAS in the prognosis of lung adenocarcinoma patients
Overall survival of LUAD patients according to K-Ras4A expression and proportion. The first (a, b, and c) and second rows (d, e, and f) indicate the curves for the KAexphigh versus KAexplow groups and KAprophigh versus KAproplow groups, respectively. The first (a and d), second (b and e), and third columns (c and f) represent the curves for all patients, patients with KRAS mutations (KRASmut group), and patients with KRAS amplification (KRASamp(+) group), respectively. X- and y-axes represent survival time (days) and survival ratio, respectively